31 results
S-1
EX-10.10
BOLT
Bolt Biotherapeutics Inc
15 Jan 21
IPO registration
3:58pm
(this “Agreement”).
1. Starting Salary and Target Bonus. Commencing on your Start Date, you will receive an annual base salary of $450,000, which will be paid semi … -monthly in accordance with the Company’s normal payroll procedures. You will also be eligible to receive an annual target bonus of up to 40% of your
DRS/A
EX-10.11
BOLT
Bolt Biotherapeutics Inc
11 Sep 20
Draft registration statement (amended)
12:00am
procedures.
Target Bonus:
You will be eligible to receive an annual target bonus of thirty-five percent (35%) of your effective base salary … on a calendar year basis (pro-rated for a partial year based upon your actual start date with Bolt). The actual amount of your annual bonus will be comprised
DRS/A
EX-10.10
BOLT
Bolt Biotherapeutics Inc
11 Sep 20
Draft registration statement (amended)
12:00am
(this “Agreement”).
1. Starting Salary and Target Bonus. Commencing on your Start Date, you will receive an annual base salary of $450,000, which will be paid semi … -monthly in accordance with the Company’s normal payroll procedures. You will also be eligible to receive an annual target bonus of up to 40% of your
DRS/A
EX-10.13
BOLT
Bolt Biotherapeutics Inc
11 Sep 20
Draft registration statement (amended)
12:00am
procedures.
Target Bonus:
You will be eligible to receive an annual target bonus of thirty-five percent (35%) of your effective base salary … on a calendar year basis (pro-rated for a partial year based upon your actual start date with Bolt). The actual amount of your annual bonus will be comprised
S-1
EX-10.13
BOLT
Bolt Biotherapeutics Inc
15 Jan 21
IPO registration
3:58pm
procedures.
Target Bonus:
You will be eligible to receive an annual target bonus of thirty-five percent (35%) of your effective base salary … on a calendar year basis (pro-rated for a partial year based upon your actual start date with Bolt). The actual amount of your annual bonus will be comprised
S-1
EX-10.24
jf94bk0r 9pa
15 Jan 21
IPO registration
3:58pm
S-1
EX-10.11
i09dfwateev5kikhgp1
15 Jan 21
IPO registration
3:58pm
S-1
EX-10.12
prmneu9tlt9fk3mra1
15 Jan 21
IPO registration
3:58pm
DRS/A
EX-10.12
tdj9lqeb07l9yt6
11 Sep 20
Draft registration statement (amended)
12:00am
8-K
dvc142pm g7yqnl
14 May 24
Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team
4:06pm
DEF 14A
ancrbbjeielhac
28 Apr 22
Definitive proxy
4:06pm
S-1
q7a54
15 Jan 21
IPO registration
3:58pm
DRS/A
4nlu8oj gjaegb36qgv
11 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
792fth32
11 Sep 20
Draft registration statement (amended)
12:00am
DRS
9hblq37cojijwtlati0d
10 Aug 20
Draft registration statement
12:00am
424B4
1yp 671ixev
5 Feb 21
Prospectus supplement with pricing info
4:44pm